Korea FilingsFull brief — $39

ILYANG PHARMACEUTICAL CO.,LTD

일양약품(주) · KOSPI: 007570 · Pharmaceuticals and medicinal chemicals

Key facts

Korean name
일양약품(주)
Market / ticker
KOSPI · 007570
Industry
Pharmaceuticals and medicinal chemicals
Established
1946-07-01
Fiscal year ends
December
Website
www.ilyang.co.kr
DART corp code
00146454
Latest revenue
₩272.4B (FY2025)

Items worth checking

high
Unfaithful disclosure designation — filed 2026-09-10.
high
Listing status issue disclosed — filed 2025-11-05.
medium
Filing on change of largest shareholder or control — filed 2026-07-30.
low
Filing on a change in the CEO line-up — filed 2025-10-17.

Financial summary

KRWFY2023FY2024FY2025
Revenue₩266.7B₩268.7B₩272.4B
Operating income₩16.4B₩9.6B₩5.0B
Net income−₩2.0B₩9.3B₩7.1B
Total assets₩392.6B₩431.0B₩457.3B
Total liabilities₩163.0B₩191.5B₩215.9B
Total equity₩229.6B₩239.5B₩241.4B
Share capital₩48.8B₩48.8B₩48.8B

Consolidated statements · FY2025 operating margin 1.8% · liabilities to equity 89% · Annual report FY2025 (Korean original)

Auditor opinions

PeriodAuditorOpinion
Term 55 (current)삼정회계법인Unqualified
Term 54 (prior)한길회계법인Unqualified
Term 53 (two years prior)한길회계법인Unqualified

Largest shareholder history

No change history reported in the latest annual report.

Recent filings

DateFilingOriginal
2026-09-14Officer / major shareholder ownership reportDART
2026-09-10Designated for unfaithful disclosureDART
2026-09-10Amended: 단일판매ㆍ공급계약해지DART
2026-09-09단일판매ㆍ공급계약해지DART
2026-08-21Officer / major shareholder trading plan reportDART
2026-08-21Officer / major shareholder trading plan reportDART
2026-08-14Half-year report (2026.06)DART
2026-07-30Change of largest shareholderDART
2026-07-30Large shareholding (5%+) reportDART
2026-07-30Officer / major shareholder ownership reportDART
2026-07-30Officer / major shareholder ownership reportDART
2026-07-30Change in shareholdings of largest shareholder — Change of largest shareholderDART
2026-06-30Officer / major shareholder trading plan reportDART
2026-06-30Officer / major shareholder trading plan reportDART
2026-06-30Amended: Decision to acquire shares of another companyDART
2026-06-30Amended: Single sales / supply contract signedDART
2026-06-01Corporate governance reportDART
2026-05-28Officer / major shareholder ownership reportDART
2026-05-28Officer / major shareholder ownership reportDART
2026-05-15Quarterly report (2026.03)DART

Showing the 20 most recent of 48 filings. The full brief lists all of them.

Full brief on ILYANG PHARMACEUTICAL CO.,LTD — $39 Get the full brief

For business customers. EU companies: enter your VAT number at checkout and no VAT is charged (reverse charge).

Other Korean companies in Pharmaceuticals and medicinal chemicals

Data generated 2026-09-16 from OpenDART.

This page summarizes public filings from DART, the official electronic disclosure system of Korea. It is not investment, credit or legal advice. Figures are shown in the currency the company reports in. Titles and labels are machine-translated and may contain errors — always check the linked original filing. Source: OpenDART, Financial Supervisory Service, Korea.